Co-administration of Acetaminophen With Ibuprofen to Improve Duct-Related Outcomes in Extremely Premature Infants

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 310 participants.

Also called NCT05340582

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 310 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05340582
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Australia, Canada, Hong Kong SAR China, Ireland (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05340582. Randomized; triple masking; primary purpose treatment. Start 2022-12-12 (actual); primary completion 2027-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Co-administration of Acetaminophen With Ibuprofen to Improve Duct-Related Outcomes in Extremely Premature Infants
Condition
Patent Ductus Arteriosus After Premature Birth
Intervention (Drug)
Acetaminophen Injection
Intervention (Drug)
Ibuprofen 20 mg/mL oral suspension or Ibuprofen lysine 10 mg/mL injection solution (Neoprofen)
Intervention (Other)
Sodium chloride 0.9% injection
Lead sponsor
Mount Sinai Hospital, Canada (class: other)
Collaborator
Sunnybrook Health Sciences Centre (class: other)
Collaborator
McMaster Children's Hospital (class: other)
Collaborator
The Rotunda Hospital (class: other)
Collaborator
John Hunter Hospital (class: other government)
Collaborator
Royal Alexandra Hospital (class: other)
Collaborator
Centre de Recheche du Centre Hospitalier Université Laval (class: other)
Collaborator
Royal North Shore Hospital (class: other)
Collaborator
Prince of Wales Hospital, Shatin, Hong Kong (class: other)

Record details

Record id
cardio:ct-nct05340582
Content hash
c8bdf71f5ed12c3aaf6e5d657ec83dd6fb65277425cb3b86ed9b58bb9ba404cb